Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
NCT02726633 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2017-04-04
Summary
A Study to evaluate the utility of the ProLung China Test as an adjunct to CT scan in the diagnosis of lung cancer.
Conditions
- Solitary Pulmonary Nodule
- Multiple Pulmonary Nodules
Sponsors & Collaborators
-
Chinese Alliance Against Lung Cancer
lead OTHER
Principal Investigators
-
Chunxue Bai, MD · Chinese Alliance Against Lung Cancer
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- China
Study Locations
More Related Trials
-
Lung Cancer Diagnosis and Staging Using Ultrasound Guidance
NCT01623765 ·Status: COMPLETED
-
A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
NCT03427567 ·Status: COMPLETED
-
Non-Invasive ctDNA Methylation Detection for Lung Nodule Patients
NCT03685669 ·Status: UNKNOWN
-
Clinical Characteristics of Lung Cancer in China
NCT05423236 ·Status: UNKNOWN
-
Low-dose Protocol for Computed Tomography-guided Lung Biopsy
NCT02971176 ·Status: COMPLETED ·Phase: NA
-
Risk Stratification of Patients Using the Lung Cancer Biomarker Panel in China
NCT01928836 ·Status: COMPLETED
-
A Multi-Center Trial of the ProLung Test™
NCT01566682 ·Status: COMPLETED
-
Serum Autoantibodies in Predicting the Efficacy of Anti-PD-1 Treatment in Patients With Advanced NSCLC
NCT04372732 ·Status: UNKNOWN
-
Construction and Evaluation of the Liquid Biopsy-based Early Diagnostic Model for Lung Cancer
NCT04156360 ·Status: UNKNOWN
-
Integrative Analysis of Large-cell Lung Cancer
NCT02917369 ·Status: RECRUITING
-
Early Stage Lung Cancer Screening With Low-dose Computed Tomographic
NCT02898441 ·Status: UNKNOWN ·Phase: NA
-
Plasma Proteomic Biomarkers for Early Diagnosis of Lung Cancer
NCT05742204 ·Status: ACTIVE_NOT_RECRUITING
-
CTC in Lung Caner Patients With Bone Metastases
NCT04568291 ·Status: UNKNOWN ·Phase: NA
-
Role of Bronchoscopy in Early Lung Cancer Screening of High Risk Population
NCT02277366 ·Status: TERMINATED
-
Synthetic PET From CT Improves Precision Diagnosis and Treatment of Lung Cancer: a Prospective, Observational, Multicenter Study
NCT07243873 ·Status: RECRUITING
-
Perioperative and Postoperative Circulating Tumor Cell Monitoring in Different Stage of NSCLC
NCT07186855 ·Status: COMPLETED
-
Assessment System of Sarcopenia in Lung Cancer Patients
NCT06327594 ·Status: RECRUITING
-
Blood Sample Collection in Subjects With Pulmonary Nodules or CT Suspicion of Lung Cancer or Pathologically Diagnosed Lung Cancer
NCT03633006 ·Status: COMPLETED
-
NGS-based Comprehensive Genomic ctDNA Panel in NSCLC With Immunotherapy
NCT04636047 ·Status: UNKNOWN
-
Low-dose Computed Tomography-guided Core Needle Biopsy for Lung Nodules
NCT04217655 ·Status: COMPLETED ·Phase: NA
-
Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
NCT06644066 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for Diagnosis of Lung Cancer
NCT02050100 ·Status: COMPLETED
-
Early Adjuvant Diagnosis of Pulmonary Nodules Based on CTC.
NCT06187935 ·Status: COMPLETED
-
Artificial Intelligence-based Model for the Prediction of Occult Lymph Node Metastasis and Improvement of Clinical Decision-making in Non-small Cell Lung Cancer
NCT06684418 ·Status: RECRUITING
-
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
NCT03830619 ·Status: COMPLETED